Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 9;23(1):418.
doi: 10.1186/s12916-025-04252-2.

Health insurance status and severe mpox disease outcomes among sexual minority men in NYC: a retrospective cohort study

Affiliations

Health insurance status and severe mpox disease outcomes among sexual minority men in NYC: a retrospective cohort study

Ofole Mgbako et al. BMC Med. .

Abstract

Background: The 2022-2023 global mpox outbreak predominantly affected sexual minority men, with notable racial/ethnic disparities in the USA. While the current literature has established the clinical predictors of severe mpox disease, little is known about the role of insurance status on clinical outcomes. We sought to characterize patients diagnosed with mpox in New York City (NYC) and examine associations between insurance status and mpox severity score (mpox-SS).

Methods: We included 143 patients aged 18 years and older between May 1, 2022, and December 31, 2023, with confirmed mpox identified through the electronic medical record. Demographics and clinical characteristics were summarized. Linear regression was performed to examine associations between insurance status and mpox-SS, controlling for race/ethnicity, high-risk condition (e.g., HIV with CD4 < 350 cells/mm3), prior vaccination with JYNNEOS or a smallpox vaccine, presence of a sexually transmitted infection (STI), and CDC Social Vulnerability Index.

Results: The mean age (SD) was 38.3 (10.2) years with 53 (37.1%) identifying as non-Hispanic White, 44 (30.8%) as Hispanic/Latino, and 30 (20.9%) as non-Hispanic Black. Over 90% were male sex at birth or identified as cisgender men and approximately 80% were sexual minority men. Ninety-six (67.1%) had private insurance, 6 (4.2%) Medicare, 35 (24.5%) Medicaid, and 4 were (2.8%) uninsured. Sixty-three (44.1%) had a confirmed HIV diagnosis, 25 (17.4%) patients had prior JYNNEOS vaccination, and 31 (21.7%) had a high-risk condition. Thirty-eight (26.6%) patients received tecovirimat; 21 (14.7%) patients were hospitalized, with 4 (2.8%) of those admitted to the ICU. The mean (SD) mpox-SS was 6.85 (3.36). In univariate analysis, lack of insurance or Medicaid status was associated significantly with more severe mpox-SS. Insurance status remained significant (p = 0.03) in multivariable models.

Conclusions: Being uninsured or on Medicaid was significantly associated with a higher mpox-SS in this diverse cohort of predominantly cisgender sexual minority men in NYC. High-risk status and lack of prior vaccination were associated with higher mpox-SS. Further studies are needed to assess the relationship between insurance, delays in access to care, or other socioeconomic inequities with severe mpox to understand the inequities beyond insurance access to prevent disparities in future outbreaks.

Keywords: Health insurance; Inequities; Mpox; Severe disease; Sociostructural factors.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study received approval from the New York University Institutional Review Board (IRB), i22-01375. Consent for publication: This study received a waiver of authorization and consent by the New York University IRB to conduct this study. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Mpox severity score distribution and correlation of mpox severity score with severe disease outcome variable. A The box plot shows those with severe mpox disease had higher mpox severity scores than those who did not develop severe disease. B This chart illustrates the distribution of the mpox severity score, overlayed by the composite severe disease variable. 0: not severe disease. 1: severe disease

Similar articles

References

    1. Mpox 2022 summary: cases. NYC Health; 2023. Available from: https://www.nyc.gov/assets/doh/downloads/pdf/monkeypox/mpox-response-dat.... Accessed 2 Jan 2025.
    1. Martin-Iguacel R, Pericas C, Bruguera A, Rosell G, Martinez E, Diaz Y, et al. Mpox: clinical outcomes and impact of vaccination in people with and without HIV: a population-wide study. Microorganisms. 2023;11(11):2701. - PMC - PubMed
    1. Cho W, Park S, Kim HJ, Lee M, Choi YS, Yeo SG, et al. Clinical characteristics and outcomes of patients with mpox during the 2022 mpox outbreak compared with those before the outbreak: a systematic review and meta-analysis. Rev Med Virol. 2024;34(1): e2508. - PubMed
    1. Angelo KM, Smith T, Camprubi-Ferrer D, Balerdi-Sarasola L, Diaz Menendez M, Servera-Negre G, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023;23(2):196–206. - PMC - PubMed
    1. Vo C, Zomorodi R, Silvera R, Bartram L, Lugo LA, Kojic E, et al. Clinical characteristics and outcomes of patients with mpox who received tecovirimat in a New York City health system. Open Forum Infect Dis. 2023;10(11):ofad552. - PMC - PubMed